Sydney (Press Release from Rare Caners, 22 April 2024); The peak body for rare cancers in Australia welcomes two new members to its Board, with seasoned public affairs professional, Kate
Steve Baker, Rare Cancers Australia
McQuestin and tech founder and entrepreneur, Steve Baker both joining the Rare Cancers Australia (RCA) ranks in recent months.
RCA Chair, Richard Vines said he was elated to have Kate McQuestin join the RCA Board, bringing a unique perspective and more than 20 years’ experience in public affairs and government relations to support and guide the organisation in its efforts.
“Kate is passionate about helping others through their cancer journey, bringing her own lived experience to the position, after being diagnosed with thyroid cancer at age 14 and subsequently a chronic immune condition,” Richard said.
“The patient experience is something we value very much at RCA, so to couple Kate’s personal journey together with her professional expertise, makes for an incredibly unique and important addition to our Board.
“Equally, I am elated to welcome Steve Baker to the Board, bringing with him almost 30 years’ experience in IT and growing his own successful IT business, Steve has a proven track record in defining, building, and delivering technology and business outcomes across a broad range of sectors, both local and global,” Richard continued.
“I’ve known Steve for many years, he has participated in our annual Kosi Challenge 11 times, and he is committed to supporting us in our mission to improve the lives and health outcomes of all Australians living with rare, complex and less common cancers.
“His long-standing connection with RCA combined with his unique skillset and experience in IT, will be an incredibly valuable addition to our Board and I’m excited to have him there,” Richard
concluded.
RCA CEO, Christine Cockburn, stated that both appointments couldn’t come at a better time, as the organisation implements its new three-year Strategic Plan which looks to strengthen RCA’s advocacy, outcomes and impact for the rare cancer community.
“As we undertake bold new initiatives derived from our Strategic Plan, it is crucial that we have a Board of Directors with a broad skillset and perspective that governs and guides our strategic direction,” Christine said.
“I’m excited by these appointments to the Board and I’m keen to get to work with both Steve and Kate, and the entire RCA Board, as we set out to achieve equity in experience and outcomes for all Australians living with cancer,” Christine concluded.
END
